Cargando…
Coronary artery disease patient-derived iPSC-hepatocytes have distinct miRNA profile that may alter lipid metabolism
Metabolic dysfunction, partly driven by altered liver function, predisposes to coronary artery disease (CAD), but the role of liver in vulnerable atherosclerotic plaque development remains unclear. Here we produced hepatocyte-like cells (HLCs) from 27 induced pluripotent stem cell (iPSC) lines deriv...
Autores principales: | Alexanova, Anna, Raitoharju, Emma, Valtonen, Joona, Aalto-Setälä, Katriina, Viiri, Leena E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886909/ https://www.ncbi.nlm.nih.gov/pubmed/36717592 http://dx.doi.org/10.1038/s41598-023-28981-7 |
Ejemplares similares
-
Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019) -
Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells
por: Kiamehr, Mostafa, et al.
Publicado: (2017) -
A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production
por: Manzini, Stefano, et al.
Publicado: (2015) -
Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures
por: Suominen, Siiri, et al.
Publicado: (2023) -
Analysis of Drug Effects on iPSC Cardiomyocytes with Machine Learning
por: Juhola, Martti, et al.
Publicado: (2020)